685 related articles for article (PubMed ID: 25695964)
1. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.
Ntaios G; Lip GY; Lambrou D; Papavasileiou V; Manios E; Milionis H; Spengos K; Makaritsis K; Vemmos K
Neurology; 2015 Mar; 84(12):1213-9. PubMed ID: 25695964
[TBL] [Abstract][Full Text] [Related]
2. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
4. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
5. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
6. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
7. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
8. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
9. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
11. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
12. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
Glotzer TV; Hellkamp AS; Lee KL; Lamas GA
Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
[TBL] [Abstract][Full Text] [Related]
14. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
[TBL] [Abstract][Full Text] [Related]
15. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
16. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
18. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
19. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
[TBL] [Abstract][Full Text] [Related]
20. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.
Ntaios G; Vemmos K; Lip GY; Koroboki E; Manios E; Vemmou A; Rodríguez-Campello A; Cuadrado-Godia E; Giralt-Steinhauer E; Arnao V; Caso V; Paciaroni M; Diez-Tejedor E; Fuentes B; Pérez Lucas J; Arauz A; Ameriso SF; Hawkes MA; Pertierra L; Gómez-Schneider M; Bandini F; Chavarria Cano B; Iglesias Mohedano AM; García Pastor A; Gil-Núñez A; Putaala J; Tatlisumak T; Barboza MA; Athanasakis G; Makaritsis K; Papavasileiou V
Stroke; 2016 Sep; 47(9):2278-85. PubMed ID: 27507859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
